Psoriasis, one of the most common chronic skin diseases, is still a current problem in medicine. It is a systemic immune-associated recurrent dermatosis of a multifactorial nature. Modern knowledge defines psoriasis as a systemic disease which includes a complex of interdependent pathogenetic links, attaching great importance to immunological and exchange violations in an organism. Clinical manifestations of psoriasis is the most varied: from single rashes on the skin before the expressed changes of integuments, nail plates and damage to joints. The uthors presented a clinical case of successful treatment of psoriasis with the Russian-made biological drug Netakimab (Efleira) and believe that it opens new opportunities in therapy of severe forms of this disease.
No takes yet. Share an insight, caveat, or question.
Gn et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: